NASDAQ: HSCS
Heartsciences Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their HSCS stock forecasts and price targets.

Forecast return on equity

Is HSCS forecast to generate an efficient return?

Forecast return on assets

Is HSCS forecast to generate an efficient return on assets?

Company
-263.34%
Industry
11.78%
HSCS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HSCS earnings per share forecast

What is HSCS's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$2.94
Avg 2 year Forecast
-$2.05

HSCS revenue forecast

What is HSCS's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$17.3k+283.71%
Avg 2 year Forecast
$3.2M+70,999.8%
HSCS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HSCS revenue growth forecast

How is HSCS forecast to perform vs Medical Devices companies and vs the US market?

Company
2,566.45%
Industry
7.23%
Market
14.61%
HSCS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HSCS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HSCS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
HSCS$3.13N/AN/A
BDMD$0.48N/AN/A
LFWD$5.61N/AN/A
MODD$1.95N/AN/A
CTSO$5.32N/AN/A

Heartsciences Stock Forecast FAQ

What is HSCS's earnings growth forecast for 2027-2028?

(NASDAQ: HSCS) Heartsciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 28.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 65.97%.

Heartsciences's earnings in 2026 is -$10,259,225.On average, 4 Wall Street analysts forecast HSCS's earnings for 2027 to be -$14,100,985, with the lowest HSCS earnings forecast at -$13,548,005, and the highest HSCS earnings forecast at -$14,515,720.

In 2028, HSCS is forecast to generate -$9,841,313 in earnings, with the lowest earnings forecast at -$9,455,379 and the highest earnings forecast at -$10,130,763.

If you're new to stock investing, here's how to buy Heartsciences stock.

What is HSCS's revenue growth forecast for 2027-2028?

(NASDAQ: HSCS) Heartsciences's forecast annual revenue growth rate of 2,566.45% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.23%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.58%.

Heartsciences's revenue in 2026 is $4,519.On average, 4 Wall Street analysts forecast HSCS's revenue for 2027 to be $83,235, with the lowest HSCS revenue forecast at $79,971, and the highest HSCS revenue forecast at $85,683.

In 2028, HSCS is forecast to generate $15,422,953 in revenue, with the lowest revenue forecast at $14,818,131 and the highest revenue forecast at $15,878,969.

What is HSCS's forecast return on assets (ROA) for 2027-2028?

(NASDAQ: HSCS) forecast ROA is -263.34%, which is lower than the forecast US Medical Devices industry average of 11.81%.

What is HSCS's Earnings Per Share (EPS) forecast for 2027-2028?

(NASDAQ: HSCS) Heartsciences's current Earnings Per Share (EPS) is -$3.21. On average, analysts forecast that HSCS's EPS will be -$2.94 for 2027, with the lowest EPS forecast at -$2.82, and the highest EPS forecast at -$3.02. In 2028, HSCS's EPS is forecast to hit -$2.05 (min: -$1.97, max: -$2.11).

What is HSCS's forecast return on equity (ROE) for 2027-2028?

(NASDAQ: HSCS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.